News on Smallpox from BioPortfolio.com http://www.BioPortfolio.com Consolidated Smallpox news from BioPortfolio.com Wed, 10 Feb 2010 09:01:07 GMT en Immunization: Studies from SIGA Technologies, Inc. yield new data on immunizationhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4010896&HITNO=0&MSIZE=65&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Smallpox&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4010896&THISHREF=http://c.moreover.com/click/here.pl%3fz2522665860%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4010896&HITNO=0&MSIZE=65&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Smallpox&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4010896&THISHREF=http://c.moreover.com/click/here.pl%3fz2522665860%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNewsRX: Studies from SIGA Technologies, Inc. yield new data on immunizationhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4010711&HITNO=1&MSIZE=65&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Smallpox&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4010711&THISHREF=http://c.moreover.com/click/here.pl%3fz2522585818%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4010711&HITNO=1&MSIZE=65&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Smallpox&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4010711&THISHREF=http://c.moreover.com/click/here.pl%3fz2522585818%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNewsRX: Epidermal injury and infection during poxvirus immunization is crucial for the generation of highly protective T cellmediated immunityhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4016142&HITNO=2&MSIZE=65&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Smallpox&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4016142&THISHREF=http://c.moreover.com/click/here.pl%3fz2524649553%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4016142&HITNO=2&MSIZE=65&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Smallpox&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4016142&THISHREF=http://c.moreover.com/click/here.pl%3fz2524649553%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNature Medicine: Inovio Debuts Skin Electroporation Technology for Delivering DNA ...http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4010739&HITNO=3&MSIZE=65&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Smallpox&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4010739&THISHREF=http://c.moreover.com/click/here.pl%3fz2522593763%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4010739&HITNO=3&MSIZE=65&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Smallpox&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4010739&THISHREF=http://c.moreover.com/click/here.pl%3fz2522593763%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comZibb: Inovio Debuts Skin Electroporation Technology for Delivering DNA Vaccineshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4010613&HITNO=4&MSIZE=65&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Smallpox&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4010613&THISHREF=http://c.moreover.com/click/here.pl%3fz2522539498%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4010613&HITNO=4&MSIZE=65&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Smallpox&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4010613&THISHREF=http://c.moreover.com/click/here.pl%3fz2522539498%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTradingMarkets: Inovio Unveils Skin Electroporation Technology for Delivering DNA Vaccineshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4003476&HITNO=5&MSIZE=65&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Smallpox&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4003476&THISHREF=http://c.moreover.com/click/here.pl%3fz2519525746%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4003476&HITNO=5&MSIZE=65&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Smallpox&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4003476&THISHREF=http://c.moreover.com/click/here.pl%3fz2519525746%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comKeep Media: WHO Hails New Gates Foundation Support For Decade Of Vaccineshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4001692&HITNO=6&MSIZE=65&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Smallpox&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4001692&THISHREF=http://c.moreover.com/click/here.pl%3fz2518537214%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4001692&HITNO=6&MSIZE=65&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Smallpox&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4001692&THISHREF=http://c.moreover.com/click/here.pl%3fz2518537214%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMediLexicon: WHO Hails New Gates Foundation Support For Decade Of Vaccineshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4000715&HITNO=7&MSIZE=65&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Smallpox&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4000715&THISHREF=http://c.moreover.com/click/here.pl%3fz2518150748%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4000715&HITNO=7&MSIZE=65&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Smallpox&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4000715&THISHREF=http://c.moreover.com/click/here.pl%3fz2518150748%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMedical News Today: Refusing whooping cough vaccine shown to raise riskhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4000841&HITNO=8&MSIZE=65&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Smallpox&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4000841&THISHREF=http://c.moreover.com/click/here.pl%3fz2518208366%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4000841&HITNO=8&MSIZE=65&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Smallpox&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4000841&THISHREF=http://c.moreover.com/click/here.pl%3fz2518208366%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comEdmonton Journal: Danish Bavarian Nordic gets DKK298m capital injectionhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3999342&HITNO=9&MSIZE=65&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Smallpox&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3999342&THISHREF=http://c.moreover.com/click/here.pl%3fz2517413674%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3999342&HITNO=9&MSIZE=65&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Smallpox&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3999342&THISHREF=http://c.moreover.com/click/here.pl%3fz2517413674%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTherapeutics Daily: SLU to study smallpox vaccine in fight against bioterrorismhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3993360&HITNO=10&MSIZE=65&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Smallpox&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3993360&THISHREF=http://c.moreover.com/click/here.pl%3fz2514560448%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3993360&HITNO=10&MSIZE=65&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Smallpox&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3993360&THISHREF=http://c.moreover.com/click/here.pl%3fz2514560448%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBiz Journals: Alternative prostate cancer vaccine shows promisehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3991579&HITNO=11&MSIZE=65&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Smallpox&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3991579&THISHREF=http://c.moreover.com/click/here.pl%3fz2513769547%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3991579&HITNO=11&MSIZE=65&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Smallpox&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3991579&THISHREF=http://c.moreover.com/click/here.pl%3fz2513769547%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comQualityHealth.com: WHO hails new Gates Foundation support for decade of vaccineshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3987686&HITNO=12&MSIZE=65&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Smallpox&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3987686&THISHREF=http://c.moreover.com/click/here.pl%3fz2510032375%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3987686&HITNO=12&MSIZE=65&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Smallpox&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3987686&THISHREF=http://c.moreover.com/click/here.pl%3fz2510032375%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmiWeb: Killing a Killer: What Next for Smallpox?http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3983961&HITNO=13&MSIZE=65&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Smallpox&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3983961&THISHREF=http://c.moreover.com/click/here.pl%3fz2507966716%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3983961&HITNO=13&MSIZE=65&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Smallpox&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3983961&THISHREF=http://c.moreover.com/click/here.pl%3fz2507966716%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBioscience Technology Online: A randomized, double-blind, dose-finding Phase II study to evaluate immunogenicity and safety of the third generation smallpox vaccine candidate IMVAMUNEhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3974945&HITNO=14&MSIZE=65&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Smallpox&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3974945&THISHREF=http://c.moreover.com/click/here.pl%3fz2503807877%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3974945&HITNO=14&MSIZE=65&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Smallpox&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3974945&THISHREF=http://c.moreover.com/click/here.pl%3fz2503807877%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMDLinx: